Ozawa Y - Search Results

1

Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation.

Akamatsu H, Ozawa Y, Oyanagi J, Fujimoto D, Hata A, Katakami N, Tomii K, Murakami E, Sugimoto T, Shimokawa T, Koh Y, Yamamoto N. Akamatsu H, et al. Among authors: ozawa y. Anticancer Res. 2021 Feb;41(2):911-917. doi: 10.21873/anticanres.14844. Anticancer Res. 2021. PMID: 33517297 Clinical Trial.

2

Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer.

Ozawa Y, Inui N, Naitoh T, Yasuda K, Nagayama M, Shirai T, Suganuma H, Fujii M, Nakamura H, Suda T, Chida K. Ozawa Y, et al. Lung Cancer. 2009 Jan;63(1):68-71. doi: 10.1016/j.lungcan.2008.04.007. Epub 2008 May 29. Lung Cancer. 2009. PMID: 18513824 Clinical Trial.

3

Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study.

Akamatsu H, Koh Y, Ozawa Y, Fujimoto D, Hata A, Katakami N, Tomii K, Shimokawa T, Yamamoto N. Akamatsu H, et al. Among authors: ozawa y. Clin Lung Cancer. 2018 Nov;19(6):e871-e874. doi: 10.1016/j.cllc.2018.08.001. Epub 2018 Aug 22. Clin Lung Cancer. 2018. PMID: 30197264 Free article.

4

Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.

Ozawa Y, Koda K, Akahori D, Matsui T, Hasegawa H, Kakutani T, Amano T, Tanahashi M, Niwa H, Kunimoto Y, Yamada K, Yokomura K, Suda T. Ozawa Y, et al. Anticancer Res. 2018 Oct;38(10):5937-5941. doi: 10.21873/anticanres.12939. Anticancer Res. 2018. PMID: 30275222

5

Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer.

Nakashima K, Akamatsu H, Murakami H, Niwa T, Iwamoto Y, Ozawa Y, Yokoyama T, Shoda H, Yamamoto N, Yoshioka H, Masuda K, Naito T, Mori K, Takahashi T. Nakashima K, et al. Among authors: ozawa y. Anticancer Res. 2019 Mar;39(3):1463-1468. doi: 10.21873/anticanres.13263. Anticancer Res. 2019. PMID: 30842183 Clinical Trial.

6

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.

Ikeda M, Koh Y, Teraoka S, Sato K, Kanai K, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Akamatsu K, Endo K, Higuchi M, Nakanishi M, Ueda H, Yamamoto N. Ikeda M, et al. Among authors: ozawa y. Cancer Med. 2020 Mar;9(6):2122-2133. doi: 10.1002/cam4.2846. Epub 2020 Jan 30. Cancer Med. 2020. PMID: 31999390 Free PMC article.

7

Akamatsu H, Murakami E, Oyanagi J, Shibaki R, Kaki T, Takase E, Tanaka M, Harutani Y, Yamagata N, Okuda Y, Furuta K, Sugimoto T, Teraoka S, Hayata A, Tokudome N, Ozawa Y, Mori K, Koh Y, Yamamoto N. Akamatsu H, et al. Among authors: ozawa y. Oncologist. 2020 Apr;25(4):e679-e683. doi: 10.1634/theoncologist.2019-0299. Epub 2019 Nov 19. Oncologist. 2020. PMID: 32297443 Free PMC article.

8

Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.

Nakashima K, Ozawa Y, Daga H, Imai H, Tamiya M, Tokito T, Kawamura T, Akamatsu H, Tsuboguchi Y, Takahashi T, Yamamoto N, Mori K, Murakami H. Nakashima K, et al. Among authors: ozawa y. Invest New Drugs. 2020 Dec;38(6):1854-1861. doi: 10.1007/s10637-020-00943-0. Epub 2020 May 18. Invest New Drugs. 2020. PMID: 32424780 Clinical Trial.

9

Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer.

Ozawa Y, Sugimoto T, Azuma Y, Harutani Y, Yoshikawa T, Yamamoto N, Kanai K. Ozawa Y, et al. BMJ Open. 2020 Jul 21;10(7):e037746. doi: 10.1136/bmjopen-2020-037746. BMJ Open. 2020. PMID: 32699133 Free PMC article. Clinical Trial.

10

CD24, not CD47, negatively impacts upon response to PD-1/L1 inhibitors in non-small-cell lung cancer with PD-L1 tumor proportion score < 50.

Ozawa Y, Harutani Y, Oyanagi J, Akamatsu H, Murakami E, Shibaki R, Hayata A, Sugimoto T, Tanaka M, Takakura T, Furuta K, Okuda Y, Sato K, Teraoka S, Ueda H, Tokudome N, Kitamura Y, Fukuoka J, Nakanishi M, Koh Y, Yamamoto N. Ozawa Y, et al. Cancer Sci. 2021 Jan;112(1):72-80. doi: 10.1111/cas.14705. Epub 2020 Nov 27. Cancer Sci. 2021. PMID: 33084148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,614 results

Search Page